aav cmv dio gfp (Obio Technology Corp Ltd)
86
Structured Review
Obio Technology Corp Ltd
aav cmv dio gfp
Aav Cmv Dio Gfp, supplied by Obio Technology Corp Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav+cmv+dio+gfp/9+aav+dio+efla+mcherry/pm41722850-302-4-14
Average 86 stars, based on 1 article reviews
Aav Cmv Dio Gfp, supplied by Obio Technology Corp Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav+cmv+dio+gfp/9+aav+dio+efla+mcherry/pm41722850-302-4-14
Average 86 stars, based on 1 article reviews
aav cmv dio gfp - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
Virus:Article Title: Targeting Gβγ subunits in hypothalamic AgRP neurons to treat obesity. Article Snippet: G protein-coupled receptors (GPCRs) in the central nervous system, particularly in the hypothalamus, are promising therapeutic targets for the treatment of obesity and related metabolic disorders.. However, the development of anti-obesity drugs targeting GPCRs in hypothalamus has been significantly constrained by their propensity to induce a range of adverse effects.. An alternative strategy is to directly target the G protein subunits downstream of GPCRs, potentially biasing GPCR signaling away from harmful pathways while preserving those essential for normal cellular functions. Bioprocessing:Article Title: Targeting Gβγ subunits in hypothalamic AgRP neurons to treat obesity. Article Snippet: G protein-coupled receptors (GPCRs) in the central nervous system, particularly in the hypothalamus, are promising therapeutic targets for the treatment of obesity and related metabolic disorders.. However, the development of anti-obesity drugs targeting GPCRs in hypothalamus has been significantly constrained by their propensity to induce a range of adverse effects.. An alternative strategy is to directly target the G protein subunits downstream of GPCRs, potentially biasing GPCR signaling away from harmful pathways while preserving those essential for normal cellular functions. Mutagenesis:Article Title: Targeting Gβγ subunits in hypothalamic AgRP neurons to treat obesity. Article Snippet: G protein-coupled receptors (GPCRs) in the central nervous system, particularly in the hypothalamus, are promising therapeutic targets for the treatment of obesity and related metabolic disorders.. However, the development of anti-obesity drugs targeting GPCRs in hypothalamus has been significantly constrained by their propensity to induce a range of adverse effects.. An alternative strategy is to directly target the G protein subunits downstream of GPCRs, potentially biasing GPCR signaling away from harmful pathways while preserving those essential for normal cellular functions. |